NEWS: media publications and press releases
According to a study the 90% of migraines can be treated with the enzyme DAO – Interview of RTVE to Juanjo Duelo, CEO of DR Healthcare
15 May, 2019
7/3/2013 – interview to Juanjo Duelo in rtve 24h. Language: Spanish These last hours has been spoken about migraines, from which has been made public that the fifteen percent of the world’s population suffers from these tremendous headaches that go beyond a headache. Juanjo Duelo, in addition to suffering from migraines, directs a research...
“Our market is the world and we began to be an international reference” – interview in eduscopi to Juanjo Duelo, CEO of DR Healthcare
8 May, 2019
8/5/2019 – original interview published in eduscopi The patient Congressman Affected by strong migraines for many years, Juanjo Duelo, who was dedicated to the world of finance, decided to start to learn first-hand the latest research about this symptom who accompanied him from quite young. He began to attend medical conferences that addressed the topic...
The biomedical company DR Healthcare installs a research center and production plant on the Campus of Rovira i Virgili University – Indicador d’Economia
2 April, 2019
The center will dedicate 75% of the activity in research and a 25% in the production of the enzyme DiAmine Oxidase (DAO) as an ingredient in functional foods DR Healthcare has invested 500,000 euros in this new center for research and in the production plant, both located in the Sescelades Campus of the URV (Tarragona, Spain). This biomedical company manufactured...
Events and activities on DAO deficiency
Conference “Deficiency of DiAmineOxidase (DAO) activity in pacients with migraine and its treatment with DAO enzyme as new therapeutic weapon in the prevention of the crisis”
6 March, 2014
6/03/2014 Conference “Deficiency of DiAmineOxidase (DAO) activity in pacients with migraine and its treatment with DAO enzyme as new therapeutic weapon in the prevention of the crisis”
19 February, 2014
Inaugural roundtable on Wednesday February 19 will be held at 9.00 am “Are we seeing a new syndrome? Digestive and neurological manifestations Deficit DAO (diamine oxidase)” event to be held at the College of Physicians of Madrid and will be delivered by Dr. Ramon Tormo Carnicé Specialist and Head of Gastroenterology Gastroenterology and Nutrition Unit...
Presentation of “A RANDOMIZED DOUBLED BLINDED TRIAL OF TREATMENT WITH DIAMINO-OXIDASE (DAO) IN PATIENTS WITH MIGRAINE AND DEFICIT OF ENZYME’S ACTIVITY. ” in the XXI World Congress of Neurology in Vienna
22 September, 2013
22/09/2013 Presentation in the XXI World Congress of Neurology (Vienna, Austria) of the study: A RANDOMIZED DOUBLED BLINDED TRIAL OF TREATMENT WITH DIAMINO-OXIDASE (DAO) IN PATIENTS WITH MIGRAINE AND DEFICIT OF ENZYME’S ACTIVITY.